Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as ...

BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for patients with classical complement-mediated autoimmune,

Related Keywords

Brisbane ,Queensland ,Australia ,Michigan ,United States ,Jamie Dananberg ,Sheryl Seapy ,Chelcie Lister ,Takeda Pharmaceuticals ,University Of Michigan ,Strategic Communications ,Tufts University ,Eli Lilly Co ,Annexon Inc ,Douglas Love ,Eli Lilly ,Region ,